Status:
ACTIVE_NOT_RECRUITING
EMA-Guided Maintenance TMS for Depression
Lead Sponsor:
Butler Hospital
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this study is to evaluate the use of ecological-momentary-assessment (EMA) as a method for scheduling maintenance treatments for patients with Major Depressive Disorder (MDD) who responded...
Detailed Description
Repetitive Transcranial Magnetic Stimulation (rTMS or simply '"TMS") is a FDA approved non-invasive treatment modality for treatment-resistant MDD. While the current standard of care defines the treat...
Eligibility Criteria
Inclusion
- Patients with primary Major Depressive Disorder who responded (50% drop in score from pre-treatment baseline to final score on depression scale) to a standard acute course of TMS Therapy at Butler Hospital.
- PHQ-9 \<10
- Must have access to smart phone and ability to use electronic device
- Continues to meet standard eligibility criteria for clinical TMS procedures and have been medically cleared to receive treatments, per physician judgement.
Exclusion
- •Per physician judgement: Meets standard clinical exclusion criteria for TMS based on safety, e.g., seizure disorder, significant brain injury/intracranial mass, implanted ferromagnetic metal within 30mm of the TMS coil, etc.
Key Trial Info
Start Date :
September 25 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 25 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06145594
Start Date
September 25 2023
End Date
September 25 2026
Last Update
December 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Butler Hospital
Providence, Rhode Island, United States, 02906